Rocket, Lab

Rocket Lab Stock Soars on Historic Government Contract

24.12.2025 - 16:52:04

Rocket Lab USA US7731221062

Rocket Lab USA is experiencing one of its most significant weeks as a public company. A massive U.S. government contract, a new annual launch record, and a sharply increased price target from analysts have propelled its shares toward all-time highs. This surge raises a pivotal question for investors: to what extent has this renewed optimism already been factored into the current valuation?

The company's operational performance provides a strong foundation for the recent enthusiasm. On Sunday, December 21, Rocket Lab successfully completed its 21st Electron launch of 2025, dubbed "The Wisdom God Guides," for the Japanese Earth observation company iQPS. This achievement sets a new annual record for the company and maintains a 100% success rate for the year. This demonstrated launch cadence and reliability clearly distinguishes Rocket Lab from other small-launch providers, many of whom continue to grapple with delays.

This rally is also occurring within a broader sector re-rating. Market speculation has been ignited by reports of a potential SpaceX initial public offering in 2026, with suggested valuations reaching $1.5 trillion. As currently the only other publicly traded company with a proven, frequently launched orbital rocket, institutional investors are increasingly viewing Rocket Lab as a scarce and strategically vital holding for exposure to the space economy.

A Landmark Deal Transforms the Backlog

The central catalyst for the stock's ascent is a new contract award from the U.S. Space Development Agency (SDA). Rocket Lab has been tasked with developing and building approximately 18 satellites for the "Tracking Layer Tranche 3" program. The contract is valued at roughly $816 million, making it by far the largest single award in the company's history. This deal effectively doubles the backlog for its Space Systems division to approximately $1.4 billion, providing significantly improved visibility into future revenue streams.

Analysts have responded positively to this development. Needham & Co. reaffirmed its "Buy" rating on Rocket Lab shares and raised its price target from $63 to $90. The firm views the SDA contract as a validation of the company's vertically integrated strategy—which combines its own launch vehicle with satellite manufacturing capabilities—and emphasizes Rocket Lab's growing role in national security space programs. Needham's new $90 target surpasses a recent upgrade to $85 by Stifel and represents the highest current price target on the market.

Should investors sell immediately? Or is it worth buying Rocket Lab USA?

Valuation Concerns and the Path Forward

The dramatic share price increase has not come without concerns. Since the start of the year, the stock has gained over 200%, with an advance of more than 80% in the past 30 days alone. This has pushed the share price to trade just below its 52-week high. Concurrently, there has been notable insider activity: CEO Peter Beck sold approximately 1.56 million shares in December. While such sales are often pre-planned for tax or personal reasons, the market frequently interprets them as a signal that valuation levels have become demanding.

Financially, Rocket Lab remains in an investment phase. The company reported a net loss of $0.03 per share for the third quarter. However, growth is accelerating, with revenue increasing 48% year-over-year. This expansion is primarily driven by the Space Systems business, which now generates more revenue than the core Launch segment.

Strategically, the focus is shifting toward 2026. The company is developing its medium-lift "Neutron" rocket, with a first flight planned for the first half of that year. Success with Neutron would position Rocket Lab to compete directly with SpaceX's Falcon 9 for larger constellation contracts and critical national security missions, significantly expanding its addressable market.

In the near term, technical indicators suggest the stock is overbought, with the 14-day Relative Strength Index (RSI) around 85—a level often viewed as a warning sign for a potential consolidation. Yet, the fundamental news flow provides support: the multi-year SDA contract secures substantial future revenue, while Electron continues to demonstrate unprecedented operational reliability.

The next key event for investors is the Needham Growth Conference on January 13-14, 2026. Management is expected to provide updates on the production ramp for the SDA satellites and the development progress of the Neutron rocket. These details will be central to determining whether Rocket Lab can justify its currently elevated expectations over the medium to long term.

Ad

Rocket Lab USA Stock: Buy or Sell?! New Rocket Lab USA Analysis from December 24 delivers the answer:

The latest Rocket Lab USA figures speak for themselves: Urgent action needed for Rocket Lab USA investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from December 24.

Rocket Lab USA: Buy or sell? Read more here...

@ boerse-global.de